How does the updated financial performance compare to consensus analyst estimates?

Short answer:

The press‑release excerpt you provided does not contain the actual Q2‑2025 financial results (revenues, earnings, cash flow, etc.) nor does it disclose the consensus analyst estimates that Wall Street was expecting. Because those key numbers are missing, we cannot directly assess whether BrainStorm Cell Therapeutics’ (BCLI) performance was above, in line with, or below the consensus outlook.

Why a direct comparison isn’t possible from the supplied text

Because none of the above data points appear in the information you shared, any quantitative comparison would be speculative.

What you would normally look for (to help you when you obtain the full release)

1. Key financial metrics (the numbers that analysts track):

   • Revenue (total and by segment, if applicable)
   • Gross profit / gross margin
   • Operating income (or loss)
   • Net income (or loss)
   • Adjusted earnings per share (EPS)
   • Cash, cash equivalents, and debt levels
   • R&D and SG&A expenses

2. Consensus estimates (typically aggregated from a pool of sell‑side analysts):

   • Revenue consensus (e.g., $X million, +/- Y%)
   • Adjusted EPS consensus (e.g., $0.XX)
   • Other metric consensus (e.g., adjusted EBITDA, operating cash flow)

3. Variance calculation (what you’d report):

   • Revenue: Reported $A M vs. consensus $B M → %Δ = (A‑B)/B × 100 (e.g., “+12% beat” or “‑8% miss”).
   • Adjusted EPS: Reported $C vs. consensus $D → %Δ (e.g., “beat by $0.05, 20% above consensus”).
   • Net loss: Sometimes analysts forecast a loss; a narrower loss can be framed as a “beat”.

4. Management’s narrative:

   • “We exceeded consensus expectations” – often a direct quote.
   • “Our results were in line with market expectations” – indicates a match.
   • “We fell short of expectations due to …” – signals a miss.

5. Analyst reaction (post‑call price moves, upgrades/downgrades) – while not part of the “consensus vs. actual” comparison, it provides a sense of how the market interprets any beat/miss.

How to obtain the missing information

1. Read the full press release – usually posted on the company’s investor‑relations website (e.g., https://investor.brainstormcell.com), or via the original PRNewswire link.
2. Check the conference‑call transcript – often released shortly after the call (e.g., on Seeking Alpha, Bloomberg, or the company’s IR site). Management will read the numbers and comment on consensus.
3. Consult financial data platforms – FactSet, Refinitiv, Bloomberg, S&P Capital IQ, or even free sites like Yahoo! Finance/MarketWatch that compile consensus estimates for OTCQB stocks.
4. Look for analyst research notes – many sell‑side houses publish a brief “Earnings Preview” that lists the consensus prior to the call and an “Earnings Reaction” afterward.

What to do next

• Retrieve the full earnings release (or the earnings deck) for Q2 2025. It will list the actual results and often include a “Consensus Estimates” table.
• Compare the numbers using the variance formulas above.
• Summarize the comparison in a concise statement, e.g.:
  > “BrainStorm reported Q2 revenue of $12.3 M, which was +15% above the FactSet consensus of $10.7 M. Adjusted EPS came in at $‑0.08, a $0.02 beat (≈20% higher) versus the $‑0.10 consensus. Net loss narrowed to $8.5 M from $9.3 M expected, representing a modest beat on the loss estimate.”

Until those data are in hand, any answer would be purely conjectural. If you can provide the actual numbers from the release (or a link to the full announcement), I can immediately compute the precise beat/miss percentages and give you a fully detailed comparison.